GLP-1

New study examines stigma toward women who lose weight using GLP-1 medications - EurekAlert!

Some GLP-1 drugs are more effective for those with specific gene variants

One in 10 people may have resistance to GLP-1 diabetes drugs - EurekAlert!

Penn researchers use AI to surface unreported GLP-1 side effects in Reddit posts - EurekAlert!

AI-based monitoring reveals protein deficiencies in people taking GLP-1 receptor agonists for weight loss - EurekAlert!

How well GLP-1 weight loss drugs work may depend on your genetics

GLP-1 receptor agonists and noncardiometabolic outcomes - EurekAlert!

As demand for GLP-1 pills and shots surges, healthy habits are still key

GLP-1 microdosers are chasing longevity

Beyond weight loss—how the GLP-1 story is evolving

Wegovy may have highest eye stroke and sight loss risk of semaglutide GLP-1 agonists— Odds of ischaemic optic neuropathy(caused by inadequate/interrupted blood flow to the optic nerve, resulting in sudden vision loss in one or both eyes) nearly 5 times higher than among users of Ozempic

Holding vs continuing GLP-1/GIP agonists before upper endoscopy - EurekAlert!

What happens when patients stop taking GLP-1 drugs? New Cleveland Clinic study reveals real world insights - EurekAlert!

Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists - EurekAlert!

Digital microsteps as scalable adjuncts for adults using GLP-1 receptor agonists - EurekAlert!

How do GLP-1 agonists affect gene expression? - EurekAlert!

Novel plant-based approach to a better, cheaper GLP-1 delivery system - EurekAlert!

GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death - EurekAlert!

GLP-1 diabetes medications lower risk of all kinds of substance use disorders, study finds

GLP-1 drugs linked to lower addiction rates in large study of veterans